MZ

Mark Zoller

SE Senomyx: 40 patents #8 of 103Top 8%
Genentech: 18 patents #132 of 2,392Top 6%
AP Ariad Pharmaceuticals: 3 patents #27 of 77Top 40%
FI Firmenich Incorporated: 3 patents #17 of 66Top 30%
📍 Village of La Jolla, CA: #41 of 2,316 inventorsTop 2%
🗺 California: #5,035 of 386,348 inventorsTop 2%
Overall (All Time): #33,820 of 4,157,543Top 1%
65
Patents All Time

Issued Patents All Time

Showing 51–65 of 65 patents

Patent #TitleCo-InventorsDate
5780279 Method of selection of proteolytic cleavage sites by directed evolution and phagemid display David Matthews, James A. Wells 1998-07-14
5770426 Tissue plasminogen activator having zymogenic or fibrin specific properties Stephen Anderson, William F. Bennett, David Botstein, Deborah L. Higgins, Nicholas Paoni 1998-06-23
5728567 Tissue plasminogen activator having zymogenic or fibrin specific properties Stephen Anderson, William F. Bennett, David Botstein, Deborah L. Higgins, Nicholas Paoni 1998-03-17
5714145 Tissue plasminogen activator having zymogenic or fibrin specific properties Stephen Anderson, William F. Bennett, David Botstein, Deborah L. Higgins, Nicholas Paoni 1998-02-03
5616486 Tissue plasminogen activator having zymogenic or fibrin specific properties Stephen Anderson, William F. Bennett, David Botstein, Deborah L. Higgins, Nicholas Paoni 1997-04-01
5614190 Tissue plasminogen activator having zymogenic or fibrin specific properties Stephen Anderson, William F. Bennett, David Botstein, Deborah L. Higgins, Nicholas Paoni 1997-03-25
5520913 Tissue plasminogen activator having zymogenic properties Stephen Anderson, William F. Bennett, David Botstein, Deborah L. Higgins, Nicholas Paoni 1996-05-28
5411871 Method for identifying tissue plasminogen activator having zymogenic or fibrin specific properties Stephen Anderson, William F. Bennett, David Botstein, Deborah L. Higgins, Nicholas Paoni 1995-05-02
5405771 Tissue plasminogen activator having zymogenic or fibrin specific properties Stephen Anderson, William F. Bennett, David Botstein, Deborah L. Higgins, Nicholas Paoni 1995-04-11
5338546 Tissue plasminogen activator variants with decreased clearance William F. Bennett, Bruce Keyt 1994-08-16
5262170 Tissue plasminogen activator having zymogenic or fibrin specific properties and substituted at amino acid positions 296-299, DNA molecules encoding them, vectors, and host cells Stephen Anderson, William F. Bennett, David Botstein, Deborah L. Higgins, Nicholas Paoni 1993-11-16
5258180 Tissue plasminogen activator having fibrin specific properties and deletion of amino acids 466-970, compositions and methods of treatment John F. Gill, Leonard G. Presta 1993-11-02
5246850 DNA molecules encoding human tissue plasminogen activator variants with decreased clearance, vectors, and host cells William F. Bennett, Bruce Keyt 1993-09-21
5156969 Tissue plasminogen activator variant with deletion of amino acids 466-470 having fibrin specific properties John F. Gill, Leonard G. Presta 1992-10-20
5108901 Tissue plasminogen activator having zymogenic or fibrin specific properties Stephen Anderson, William F. Bennett, David Botstein, Deborah L. Higgins, Nicholas Paoni 1992-04-28